Arthur M. Krieg, Chief Scientific Officer at Checkmate Pharmaceuticals, Inc. (CMPI), bought 50,002 shares at $6.97 ($349K) on 2021-05-18, disclosed to the SEC on 2021-05-19.
Open-market purchase of $349k CMPI by Chief Scientific Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.97 | 25,001 | $174K | 50.0% |
| 2 | $6.97 | 25,001 | $174K | 50.0% |
| Total | $6.97 avg | 50,002 | $349K | 100% |
| Filing → |
| CMPI | BUY | 2021-03-31 | $741K | — | Filing → |
| CMPI | BUY | 2021-03-29 | $290K | — | Filing → |
| CMPI | BUY | 2021-01-28 | $22K | — | Filing → |